Please provide your email address to receive an email when new articles are posted on . Cala Trio, a wrist-worn device that stimulates wrist nerves to disrupt tremulous activity in the brain, safely ...

Ben Duncan’s doctor asked him to draw a spiral on a sheet of notebook paper. Tremors sent his hand shaking and scribbling all over the page as he tried to draw. What was left on the paper told the ...

After getting de novo clearance for its device from the Food and Drug Administration in 2018, Cala Health touted data from a post-market analysis that it hopes will prove the device’s benefit to ...

--Wristband is a first-of-its-kind investigational wearable designed to provide dynamic, all-day, personalized relief for people with essential tremor (ET); powered by advanced AI to continuously ...

Cala Health is getting noticed, and it's not hard to figure out why. The Burlingame, CA-based company is targeting a large and under-penetrated market opportunity with its watch-like device for ...

Essential tremor (ET) is the most common type of tremor disorder, affecting approximately 7 million people in the United States.¹ It causes involuntary, rhythmic shaking, most often in the hands, ...

Please provide your email address to receive an email when new articles are posted on . A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, a bioelectronic medicine company developing wearable therapies for chronic disease, announces two validating pieces of news for the non-invasive ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations in adults with essential tremor, device maker Fasikl announced. The ...

The Food and Drug Administration approved the Exablate Neuro system as the first focused ultrasound device intended to treat essential tremor in patients who do not respond to conventional medication.